| GWAS |
- Antidepressant treatment resistance (> 2 drugs prescribed) ( 30700811
)
- Blood protein levels ( 30072576
)
- Body mass index ( 26426971
)
- Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging) ( 26252872
)
- Dementia and core Alzheimer's disease neuropathologic changes ( 25188341
)
- Metabolite levels (X-11787) ( 23934736
)
- Motion sickness ( 25628336
)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892
)
- Pneumoconiosis in silica exposure ( 24986923
)
- Protein quantitative trait loci ( 18464913
)
|
- Body mass index ( 26426971
)
- Body mass index (age>50) ( 26426971
)
- Body mass index x sex x age interaction (4df test) ( 26426971
)
- Epilepsy ( 30531953
)
- Focal epilepsy ( 30531953
)
- Generalized epilepsy ( 30531953
)
- Metabolite levels ( 23823483
)
- Obstructive sleep apnea trait (apnea hypopnea index) ( 29077507
)
- Parkinson's disease ( 28892059
)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971
)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971
)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971
)
|
